Revolution Medicines Inc [RVMD] stock is trading at $54.1, up 8.90%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RVMD shares have gain 12.15% over the last week, with a monthly amount glided 19.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 05, 2025, Truist initiated with a Buy rating and assigned a price target of $99 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $75 on August 19, 2025. Wells Fargo initiated its recommendation with a Overweight and recommended $67 as its price target on August 15, 2025. Goldman started tracking with a Buy rating for this stock on July 15, 2025, and assigned it a price target of $65. In a note dated July 16, 2024, Needham reiterated an Buy rating on this stock and boosted its target price from $46 to $62.
Revolution Medicines Inc [RVMD] stock has fluctuated between $29.17 and $62.40 over the past year. Currently, Wall Street analysts expect the stock to reach $81.17 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $54.1 at the most recent close of the market. An investor can expect a potential return of 50.04% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.42 and Total Capital is -0.4. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.28 points at the first support level, and at 50.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 56.03, and for the 2nd resistance point, it is at 57.97.
Ratios To Look Out For
For context, Revolution Medicines Inc’s Current Ratio is 11.79. Further, the Quick Ratio stands at 11.79, while the Cash Ratio is 2.18.
Transactions by insiders
Recent insider trading involved MARK A GOLDSMITH, Director, that happened on Oct 17 ’25 when 10000.0 shares were purchased. Officer, JEFFREY TODD CISLINI completed a deal on Oct 17 ’25 to buy 12000.0 shares. Meanwhile, Director MARK A GOLDSMITH bought 10000.0 shares on Oct 16 ’25.
